Kalbe Farma (Indonesia) Investor Sentiment

KLBF Stock  IDR 1,505  35.00  2.38%   
About 55% of Kalbe Farma's institutional investors are presently thinking to get in. The analysis of current outlook of investing in Kalbe Farma Tbk suggests that some traders are interested regarding Kalbe Farma's prospects. Kalbe Farma's investing sentiment shows overall attitude of investors towards Kalbe Farma Tbk.
  
over six months ago at news.google.com         
Kalbe Farma Bakal Buyback Saham Rp 1 Triliun - Liputan6.com
Google News at Macroaxis
over six months ago at news.google.com         
Video Meracik Bisnis Emiten Farmasi Pasca-Pandemi - CNBC Indonesia
Google News at Macroaxis
over six months ago at news.google.com         
Stock Pick IHSG Melesat 1,42 percent Sepekan, Rekomendasi Saham Hari Ini ERAA, BSDE dan MTEL - Barek...
Google News at Macroaxis
over six months ago at news.google.com         
Kalbe Farma The Only Healthcare Issuer Included in the High Dividend 20 Index - KONTAN
Google News at Macroaxis
over six months ago at news.google.com         
NEW UPDATE XTRA Buying Power di XTRA Day Trading - Ajaib
Google News at Macroaxis
over six months ago at news.google.com         
Financial Contrast Johnson Johnson PT Kalbe Farma Tbk. - Defense World
Google News at Macroaxis
over a year ago at news.google.com         
Analyzing AbbVie PT Kalbe Farma Tbk. - Defense World
Google News at Macroaxis
over a year ago at news.google.com         
Medica 2023 Fapon beschleunigt die Entwicklung seines ... - FinanzNachrichten.de
Google News at Macroaxis
over a year ago at news.google.com         
Stocks Pick IHSG Belum Berhasil Tembus 7.000, Ini Rekomendasi Saham KLBF, ERAA dan BBCA - Bareksa.co...
Google News at Macroaxis
over a year ago at news.google.com         
Inflasi AS Melandai Kerek Wall Street, IHSG Hijau, EDGE Stock Split 15, PTPP Divestasi Rp1,4 Triliun...
Google News at Macroaxis
over a year ago at news.google.com         
Kinerja Kalbe Meleset Jauh, Target Harga Saham Direvisi - Investor.ID
Google News at Macroaxis
over a year ago at news.google.com         
IHSG Menguat Didorong Pernyataan Dovish dari The Fed - Vibiznews.com
Google News at Macroaxis
over a year ago at news.google.com         
Daya Beli dan Volatilitas Mata Uang Membayangi Kinerja Kalbe Farma - KONTAN
Google News at Macroaxis
over a year ago at news.google.com         
MARKET REVIEW 4 Saham Ini Bikin IHSG Terkoreksi - Media Asuransi
Google News at Macroaxis
over a year ago at news.google.com         
Siasat Kalbe Farma Kimia Farma Bertahan di Tengah Pelemahan Rupiah - Bisnis.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Kalbe Farma that are available to investors today. That information is available publicly through Kalbe media outlets and privately through word of mouth or via Kalbe internal channels. However, regardless of the origin, that massive amount of Kalbe data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kalbe Farma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kalbe Farma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kalbe Farma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kalbe Farma alpha.

Kalbe Farma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Other Information on Investing in Kalbe Stock

Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.